Literature DB >> 23624156

Dual effects of exercise in dysferlinopathy.

Olivier Biondi1, Marie Villemeur, Alice Marchand, Fabrice Chretien, Nathalie Bourg, Romain K Gherardi, Isabelle Richard, François-Jérôme Authier.   

Abstract

Dysferlinopathy refers to a group of autosomal recessive muscular dystrophies due to mutations in the dysferlin gene causing deficiency of a membrane-bound protein crucially involved in plasma membrane repair. The condition is characterized by marked clinical heterogeneity, the different phenotypes/modes of presentation being unrelated to the genotype. For unknown reasons, patients are often remarkably active before the onset of symptoms. Dysferlin deficiency-related persistence of mechanically induced sarcolemma disruptions causes myofiber damage and necrosis. We postulate that limited myodamage may initially remain hidden with well-preserved resistance to physical strains. By subjecting dysferlin-deficient B6.A/J-Dysf(prmd) mice to long-term swimming exercise, we observed that concentric/isometric strain improved muscle strength and alleviated muscular dystrophy by limiting the accumulation of membrane lesions. By contrast, eccentric strain induced by long-term running in a wheel worsened the dystrophic process. Myofiber damage induced by eccentric strain increased with age, reflecting the accumulation of non-necrotic membrane lesions up to a critical threshold. This phenomenon was modulated by daily spontaneous activity. Transposed to humans, our results may suggest that the past activity profile shapes the clinical phenotype of the myopathy and that patients with dysferlinopathy should likely benefit from concentric exercise-based physiotherapy.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624156     DOI: 10.1016/j.ajpath.2013.02.045

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  9 in total

1.  Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle.

Authors:  Aurelia Defour; Sushma Medikayala; Jack H Van der Meulen; Marshall W Hogarth; Nicholas Holdreith; Apostolos Malatras; William Duddy; Jessica Boehler; Kanneboyina Nagaraju; Jyoti K Jaiswal
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

2.  Effect of Ibuprofen on Skeletal Muscle of Dysferlin-Null Mice.

Authors:  Alyssa F Collier; Jessica Gumerson; Kimmo Lehtimäki; Jukka Puoliväli; Jace W Jones; Maureen A Kane; Sankeerth Manne; Andrea O'Neill; Hillarie P Windish; Toni Ahtoniemi; Bradley A Williams; Douglas E Albrecht; Robert J Bloch
Journal:  J Pharmacol Exp Ther       Date:  2017-12-28       Impact factor: 4.030

3.  Chick embryonic cells as a source for generating in vitro model of muscle cell dystrophy.

Authors:  Verma Urja; Kashmira Khaire; Suresh Balakrishnan; Gowri Kumari Uggini
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-10-09       Impact factor: 2.416

Review 4.  Dysferlin at transverse tubules regulates Ca(2+) homeostasis in skeletal muscle.

Authors:  Jaclyn P Kerr; Christopher W Ward; Robert J Bloch
Journal:  Front Physiol       Date:  2014-03-06       Impact factor: 4.566

5.  Allele-specific expression reveals interactions between genetic variation and environment.

Authors:  David A Knowles; Joe R Davis; Hilary Edgington; Anil Raj; Marie-Julie Favé; Xiaowei Zhu; James B Potash; Myrna M Weissman; Jianxin Shi; Douglas F Levinson; Philip Awadalla; Sara Mostafavi; Stephen B Montgomery; Alexis Battle
Journal:  Nat Methods       Date:  2017-05-22       Impact factor: 28.547

6.  Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.

Authors:  Erin M Lloyd; Hongyang Xu; Robyn M Murphy; Miranda D Grounds; Gavin J Pinniger
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240

7.  Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B.

Authors:  Daniel C Bittel; Sen Chandra Sreetama; Goutam Chandra; Robin Ziegler; Kanneboyina Nagaraju; Jack H Van der Meulen; Jyoti K Jaiswal
Journal:  J Clin Invest       Date:  2022-01-04       Impact factor: 14.808

8.  Diltiazem improves contractile properties of skeletal muscle in dysferlin-deficient BLAJ mice, but does not reduce contraction-induced muscle damage.

Authors:  Morium Begam; Alyssa F Collier; Amber L Mueller; Renuka Roche; Sujay S Galen; Joseph A Roche
Journal:  Physiol Rep       Date:  2018-06

9.  A Handful of Details to Ensure the Experimental Reproducibility on the FORCED Running Wheel in Rodents: A Systematic Review.

Authors:  Daniel Garrigos; Marta Martínez-Morga; Angel Toval; Yevheniy Kutsenko; Alberto Barreda; Bruno Ribeiro Do Couto; Fernando Navarro-Mateu; José Luis Ferran
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.